Cite
HARVARD Citation
Jordan, K. et al. (2016). Intraperitoneal bevacizumab for control of malignant ascites due to advanced-stage gastrointestinal cancers: A multicentre double-blind, placebo-controlled phase II study – AIO SUP-0108. European journal of cancer. pp. 127-134. [Online].